Meera Varman
Pediatric Infectious Diseases · Boise, IDNPI 1265548762
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Sanofi Pasteur Inc. at 45.4% of the total. Reporting peaked in 2024 at $20,783 and has fallen 80.3% since, to $4,095 in 2025.
Across 82 payments — averaging $682.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi Pasteur Inc.$25K
- Seqirus USA Inc$19K
- Merck$5K
- Modernatx, Inc.$3K
- GSK$2K
- AstraZeneca$1K
- plus $19 from 2 others
Across 527 payments — averaging $2709.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$804K
- Pfizer$287K
- Sanofi Pasteur Inc.$200K
- Merck$114K
- AstraZeneca$17K
- Astrazeneca UK Limited$6K
What the payments were for
- Consulting fees$21,09738%
- Speaking & faculty fees$23,41142%
- Travel & lodging$8,73816%
- Food & beverage$2,6905%
- Education$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi Pasteur Inc. | 29 | $25,413 |
| Seqirus USA Inc | 12 | $19,032 |
| Merck | 24 | $5,240 |
| Modernatx, Inc. | 2 | $2,887 |
| GSK | 1 | $1,918 |
| AstraZeneca | 12 | $1,439 |
| Abbott | 1 | $18 |
| Pfizer | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BEYFORTUS$14,877
- mResvia$2,887
- MENQUADFI$1,576
- V114$1,500
- NO PRODUCT DISCUSSED$949
How this compares
Too few pediatric infectious diseases providers in Idahoto place this figure against a meaningful peer group, so we don't.
Other pediatric infectious diseases in Boise
- Ingrid LundgrenBoise$67
- Lynn LuginbuhlBoise$52
- Joseph HilinskiBoise$52
- Thomas RandBoise$21
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.